CN

About Us

Slogan


Heal for Science. Sun for Life



Mission


Craft innovation with rigor. Safeguard health with integrity.



Vision


Nurture life with warm technology. Bring health and hope to the world.


Early-Stage Development
Cell Line Development
Biologics and ADC Process Development
IND Files Preparation and Applicaton
GMP Pilot Production
PC/PV
GMP Commercial Production
Media Development & Customization

  • R&D Center

    Providing clients with comprehensive molecular design and evaluation service, such as protein engineering, activity analysis and druggability analysis based on our high-quality protein production platforms and multiple analytical tools


  • R&D Center

    Self-developed HaoYue® Platform, which can deliver sublicensable stable cell lines with high expression

    Process development platforms


  • Production Plant

    2*250 L/500 L GMP manufacturing lines for DS and DP

    100 L GMP manufacturing line for ADC DS


  • Production Site(put into use in 2024)

    6*2000 L commercial-scale manufacturing lines for antibodies

    500 L commercial-scale manufacturing line for ADC products

2015

Founded

52500

Area

4

Sites

250+

Employees

What Our Clients Say

CTM Bio

CEO

Healsun is an highly professional and reliable CDMO. Their expertise in the field is evident in every aspect of their work. From the initial stages of a project to its completion, they demonstrate a high level of competence and commitment. Their reliability is proven through their consistent delivery of quality services. They are a trusted partner for us.

Pilatus

CEO

I strongly recommend HealSun Biopharm as a trusted, professional partner. Throughout our collaboration, they consistently demonstrated excellence, transparency, and compliance in development and manufacturing. Their team provided essential support and expert guidance, significantly benefiting our projects. We’re very pleased with their service and look forward to a continued relationship.

Development History



Nov.11

Founded


2015
2018

Aug.08

1st CLD Project Obtained IND Approval


Dec.12

Strategic Investment Obtained




Jun.06

New Headquarters Put into Use





2019
2021

Mar.03

Series A Round Completed

1st One-Stop Solution Project Obtained IND Approval


Nov.11

MFG1 Put into Use



Aug.08

Series B Round Completed




2022
2023

Oct.10

Series B+ Round Completed




Nov.11

New Funding Round Completed


Dec.12

MFG2 40,000㎡



2025
2026

MFG2 40,000m²

Put into Use


Future
0.105897s